EBITDA margin was at 27.4% as against 26% (YoY).
Dr Lal PathLabs Q4 net profit stood at Rs.32.5 crore.
EBITDA margin was at 27.4% as against 26% (YoY).
EBITDA margin was at 27.4% as against 26% (YoY).
EBITDA for the quarter stood at 52.5 crore.
Dr Lal Pathlabs Ltd is currently trading at Rs. 992.6, up by Rs. 11.75 or 1.2% from its previous closing of Rs. 980.85 on the BSE.
The scrip opened at Rs. 985 and has touched a high and low of Rs. 1015 and Rs. 985 respectively. So far 26200(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 8115.85 crore.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1045.75 on 11-Apr-2016 and a 52 week low of Rs. 696.5 on 20-Jan-2016. Last one week high and low of the scrip stood at Rs. 984 and Rs. 955 respectively.
The promoters holding in the company stood at 58.68 % while Institutions and Non-Institutions held 12.28 % and 27.17 % respectively.
The stock is currently trading above its 50 DMA.
No comments:
Post a Comment